Latest NeuroScience Inc. Stories
Patients and clinicians are provided with additional services focused on the diagnosis and treatment of neuropsychological conditions.
New men’s and women’s formulations address imbalances at the source. Osceola, WI (PRWEB) November 22, 2013 NeuroScience, Inc., a national leader
OSCEOLA, Wis., Jan. 11 /PRNewswire/ -- NeuroScience, Inc. has launched a comprehensive and customizable dietary program based on patients' food sensitivity test results.
OSCEOLA, Wis., Aug. 4 /PRNewswire/ -- NeuroScience, Inc. has launched a new product -- Avipaxin -- aimed at decreasing elevated levels of pro-inflammatory cytokines.
OSCEOLA, Wis., June 11 /PRNewswire/ -- NeuroScience, Inc. has launched an antioxidant protocol that combines an objective assessment of glutathione levels along with unique antioxidant compounds, including OSR#1, CysNAC, and NeuroVitamins.
OSCEOLA, Wis., May 12 /PRNewswire/ -- NeuroScience, Inc. has launched NeuroSLP, a medical protocol that tests for potential imbalances in the hormones and neurotransmitters that regulate sleep. This protocol enhances a clinician's ability to make more informed decisions regarding patient care.
- an ornament or knob in the shape of a flower